About
Orgenesis Inc. is a global biotech company committed to unlocking the potential of cell and gene therapies (CGTs) and pioneering a decentralized approach to processing since 2020. This new model allows Orgenesis to bring academia, hospitals, and industry together to advance CGTs toward eventual commercialization.